Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Acute Pain × Meloxicam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Pain, Postoperative 1 Lymphoma, Follicular 1 Hodgkin Disease 1 Chronic Pain 1 Acute Pain 1

Interventions

Ketamine 4 Oxycodone 2 Diclofenac 2 Anesthesia, General 2 Acetaminophen 2 Transcutaneous Electric Nerve Stimulation 1 Tea 1 Surveys and Questionnaires 1 Ropivacaine 1 Psychotherapy 1 Pregabalin 1 Passive Cutaneous Anaphylaxis 1 Minocycline 1 Meloxicam 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Ibuprofen 1 Hydromorphone 1 Gabapentin 1 Fentanyl 1 Ethyl Chloride 1 Epinephrine 1 Duloxetine Hydrochloride 1 Diathermy 1 Cryotherapy 1 Control Groups 1 Bupivacaine 1 Anti-Inflammatory Agents, Non-Steroidal 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed

Lymphoma, Follicular, Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡